The factors with p < 0.1 in the Kaplan–Meier survival analysis and potentially affecting the PFS/OS in patients (Table 3; Supplementary Table 2), namely ALB, hyperlipidemia, reproductive history, menopausal status, age, ascites, pathology, FIGO stage, residual tumor classification, cancer antigen 125 (CA125)-negative time, response to first-line chemotherapy and PARPi were included in the multivariable Cox regression analysis. The gene discussed is MUC16; the disease is neoplasm.